BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nilsson LM, Zhang L, Bondar A, Svensson D, Wernerson A, Brismar H, Scott L, Aperia A. Prompt apoptotic response to high glucose in SGLT-expressing renal cells. Am J Physiol Renal Physiol 2019;316:F1078-89. [PMID: 30864838 DOI: 10.1152/ajprenal.00615.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Tian J, Sodhi K, Shapiro JI. The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road? J Membr Biol 2021. [PMID: 34297135 DOI: 10.1007/s00232-021-00192-z] [Reference Citation Analysis]
2 Packer M. Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics. Am J Kidney Dis 2021;77:280-6. [PMID: 32711072 DOI: 10.1053/j.ajkd.2020.04.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
3 Bernhem K, Fontana JM, Svensson D, Zhang L, Nilsson LM, Scott L, Blom H, Brismar H, Aperia A. Super-resolution microscopy reveals that Na+/K+-ATPase signaling protects against glucose-induced apoptosis by deactivating Bad. Cell Death Dis 2021;12:739. [PMID: 34315852 DOI: 10.1038/s41419-021-04025-8] [Reference Citation Analysis]
4 Hou YC, Zheng CM, Yen TH, Lu KC. Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection. Int J Mol Sci 2020;21:E7833. [PMID: 33105763 DOI: 10.3390/ijms21217833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Aperia A, Brismar H, Uhlén P. Mending Fences: Na,K-ATPase signaling via Ca2+ in the maintenance of epithelium integrity. Cell Calcium 2020;88:102210. [PMID: 32380435 DOI: 10.1016/j.ceca.2020.102210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 He L, Li Q, Du C, Xue Y, Yu P. Glis2 inhibits the epithelial-mesenchymal transition and apoptosis of renal tubule cells by regulating the β-catenin signalling pathway in diabetic kidney disease. Biochemical and Biophysical Research Communications 2022;607:73-80. [DOI: 10.1016/j.bbrc.2022.03.111] [Reference Citation Analysis]
7 Duan S, Lu F, Song D, Zhang C, Zhang B, Xing C, Yuan Y. Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease. Front Endocrinol (Lausanne) 2021;12:661185. [PMID: 34177803 DOI: 10.3389/fendo.2021.661185] [Reference Citation Analysis]
8 Yang Z, Li T, Xian J, Chen J, Huang Y, Zhang Q, Lin X, Lu H, Lin Y. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy. FASEB J 2022;36:e22410. [PMID: 35713937 DOI: 10.1096/fj.202200243R] [Reference Citation Analysis]
9 Afsar B, Hornum M, Afsar RE, Ertuglu LA, Ortiz A, Covic A, van Raalte DH, Cherney DZI, Kanbay M. Mitochondrion-driven nephroprotective mechanisms of novel glucose lowering medications. Mitochondrion 2021;58:72-82. [PMID: 33677060 DOI: 10.1016/j.mito.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]